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Abstract
OBJECTIVE: To examine the influence of admission serum cholesterol levels (SCL) on severity of
initial neurological deficit, neurological outcome at month 3 and neurological recovery in patients with
acute first-ever ischemic stroke. METHODS: Prospectively collected data from 889 consecutive patients
with first-ever acute ischemic stroke were retrospectively analysed. Patients who suffered a recurrent
ischemic stroke (n=22) or died (n=30) during the follow-up period were excluded from this study. Age,
gender, arterial hypertension, diabetes mellitus, smoking, stroke etiology, SCL and severity of
neurological deficit, using the National Institute of Health Stroke Scale (NIHSS), at presentation
(NIHSS0) and after 3 months (NIHSS1), were assessed. Neurological recovery was defined as
difference in NIHSS score (Delta(NIHSS)), according to Delta(NIHSS)=NIHSS0 - NIHSS1. RESULTS:
Data from 837 patients (66% men, age: 62 +/- 14 years) were analysed. NIHSS1 was 2.3 +/- 1.8 and
Delta(NIHSS) was 3.4 +/- 3. Clinically insignificant correlations between SCL and NIHSS0 (r=-0.13,
p=0.0002), NIHSS1 (r=-0.09, p=0.001) and Delta(NIHSS) (r=-0.1, p=0.03) were evident. Multivariate
binary logistic regression analysis revealed smoking (p=0.008), stroke etiology (p=0.023) and NIHSS0
(p<0.001) but not age, gender, arterial hypertension, diabetes mellitus or SCL as predictors for
Delta(NIHSS). CONCLUSION: Our data suggest that SCL in patients with acute ischemic stroke are
not associated with neurological deficit on admission, outcome or neurological recovery.
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 Abstract  
 
Background and Purpose: We examined the influence of admission serum cholesterol levels 
(SCL) on severity of initial neurological deficit, neurological outcome at 3 months and 
neurological recovery in patients with acute first-ever ischemic stroke. 
Methods: Prospectively collected data from 889 consecutive patients with first ever acute 
ischemic stroke were retrospectively analyzed. Patients who suffered a recurrent ischemic stroke 
(n=22) or died (n=30) during the follow-up period were excluded from this study. Age, sex, 
arterial hypertension, diabetes mellitus, smoking, stroke etiology, SCL, and severity of 
neurological deficit, using the National Institute of Health Stroke Scale (NIHSS), at presentation 
(NIHSS0) and after three months (NIHSS1) were assessed. Neurological recovery was defined as 
difference in NIHSS score (∆NIHSS), according to ∆NIHSS= NIHSS0 - NIHSS1.  
Results: Data from 837 patients, 66% men, age 62±14 years was analyzed. NIHSS1 was 2.3±1.8 
and ∆NIHSS 3.4±3. Clinically insignificant correlations between SCL and NIHSS0 (r= -0.13, 
p=0.0002), NIHSS1 (r= -0.09, p=0.001) and ΔNIHSS (r=-0.1, p=0.03) were evident. Multivariate 
binary logistic regression analysis revealed smoking (p=0.005), stroke etiology (p=0.005) and 
NIHSS0 (p<0.001) but not age, gender, arterial hypertension, diabetes mellitus or SCL as 
predictors for ΔNIHSS. 
Conclusions: Our data suggest that SCL in patients with acute ischemic stroke are not associated 
with neurological deficit on admission, outcome or neurological recovery.  
(200 words) 
  
 Introduction  
 
 Several studies described an influence of brain nutrients- specifically glucose and 
cholesterol- on outcome in patients with acute ischemic stroke. High serum glucose levels are 
unanimously considered markers of adverse outcome [1]. Up to date, two studies have examined 
the potential influence of serum cholesterol levels (SCL) on outcome in patients with acute 
ischemic stroke; one described a better outcome in patients with higher admission SCL [2], while 
the second reported a decreased mortality following acute ischemic stroke in patients taking lipid 
lowering agents at stroke onset [3]. The purpose of this study was to evaluate the hypothesis that 
SCL influence the clinical course of acute stroke patients. We therefore examined the relation 
between SCL and (1) severity of neurological deficit on admission, (2) neurological outcome at 3 
months and (3) neurological recovery in patients with first-ever ischemic stroke.  
 
Patients and Methods  
 
 Prospectively collected data from 889 consecutive patients with first ever acute ischemic 
stroke admitted in our neurological department between August 1997 and December 2004 were 
retrospectively analyzed for this study. Patients enrolled in therapeutic trials, patients who 
suffered a recurrent ischemic stroke (n=22) or patients who died (n=30) during the follow-up 
period were excluded from this study. Diagnostic work-up Cranial CT (CCT) was performed in 
all patients on admission. 12-lead ECG and ultrasound evaluation of the brain supplying 
arteries[4] were performed in all, and brain MRI, 24-h ECG monitoring and transthoracic or 
transesophageal (TEE) echocardiography in selected cases. 
  
  The following clinical characteristics were assessed: Age; sex; arterial hypertension 
defined by pre-admission history and medical records; diabetes mellitus defined either as fasting 
venous plasma glucose concentration of ≥7.0 mmol/l after an overnight fast on at least two 
separate occasions, or as venous plasma glucose concentration of ≥ 11.1 mmol/l following the 
ingestion of 75 g of oral glucose during the 2-h test; smoking; total venous SCL from blood 
drawn within 48 hours after symptom onset with the patient in supine position; severity of 
neurological deficit, using the National Institute of Health Stroke Scale (NIHSS), at presentation 
(NIHSS0) and after three months (NIHSS1). Stroke etiology was defined according to the Trial of 
Org 10172 in Acute Stroke Treatment (TOAST) classification[5] as (1) atherothrombotic in 
patients with a >50% stenosis or occlusion of the supplying cerebral artery. Patients with aortic 
plaques with a diameter of ≥ 4 mm or mobile aortic thrombi located before the ostium of the left 
subclavian artery on TEE, but no other potential stroke etiology were also assumed to have an 
atherothrombotic etiology of stroke (2) cardioembolic in patients with a potential cardiac embolic 
source, (3) lacunar in patients who presented with one of the traditional clinical lacunar 
syndromes and either normal CT / MRI or a relevant subcortical or brain stem lesion with a 
diameter < 1.5 cm, (4) stroke of other defined etiology and (5) stroke of undetermined etiology, 
when no, or more than one potential etiologies were found.  
 
Statistical analysis  
 A standard software package (SPSS 12.0) was used for statistical analysis. Quantitative 
variables were expressed as mean±standard deviation (SD). Significance was declared at p < 
0.05. 
 Neurological recovery was defined as difference in NIHSS score (∆NIHSS), according to 
∆NIHSS= NIHSS0 - NIHSS1. The influence of SCL on the initial clinical deficit (NIHSS0), 
  
 recovery (∆NIHSS) and functional outcome (NIHSS1) were examined using Pearson correlation. 
For multivariate binary logistic regression analysis with backward elimination of non-significant 
predictors, patients were divided into 2 groups of either ΔNIHSS ≤ 0 (worsening or no clinical 
improvement during follow up) or > 0 (improvement during follow up). Age (continuous 
variable), gender, SCL (continuous variable), diabetes mellitus (yes/no), arterial hypertension 
(yes/no), smoking (yes/no), stroke etiology (cardioembolic/ atherothrombotic/ lacunar/ other 
known/ unknown etiology) and NIHSS0 (continuous variable) served as possible predictors. 
Since the relationship between ∆NIHSS and SCL was the main interest of this study, latter variable 
was kept in the model, even if not significant.  
 
Results  
 
 Data from 837 patients, 66% men, age 62±14 years (mean±SD, minimum 16, maximum 
90 years) was analyzed. Arterial hypertension was found in 526 (63%) and diabetes mellitus in 
128 (15%) patients. NIHSS0 score was 6±5 (mean±SD; minimum 0, maximum 40). Etiology of 
stroke was atherothrombotic in 238 (28%), cardioembolic in 156 (19%), lacunar in 181 (22%), 
other determined etiology in 82 (10%) and undetermined in 210 (25%) patients. NIHSS1 was 
2.3±1.8 (mean±SD; minimum 0, maximum 22) and ∆NIHSS 3.4±3 (mean±SD; minimum -7, 
maximum 28). Clinically insignificant correlations between SCL and NIHSS0 (r= -0.13, 
p=0.0002), NIHSS1 (r= -0.09, p=0.009; Figure 1) and ΔNIHSS (r=-0.1, p=0.03, all Pearson test) 
were evident. 
 Multivariate binary logistic regression analysis with backward elimination of non-
significant predictors revealed smoking (p=0.005), stroke etiology (p=0.005) and NIHSS0 
  
 (p<0.001) but not age (p=0.995), gender (p=0.79), arterial hypertension (p=0.4), diabetes mellitus 
(p=0.96) and SCL (p=0.89) as predictors for ΔNIHSS ≤ 0 or > 0 (Table 1).  
  
 Discussion  
 
 A previous study demonstrated a worse outcome in patients with admission SCL < 6.5 
mmol/l, as compared to remaining patients at one month follow-up[2]. The present study could 
not confirm this finding: even though the correlations between SCL and the clinical measures 
(NIHSS0, NIHSS1, ΔNIHSS) were statistically significant, the low r-values suggest that this result is 
of no clinical relevance. The reason for the discrepancy between our results and those of the 
previous paper could be methodological differences, particularly concerning duration of follow-
up (one month in the previous and three in our study) and dichotomization of SCL at 6.5 mmol/l. 
It could be argued that our failure to reproduce the results of the former study was simply due to 
the lower number of enrolled patients. However, the results of our statistical analysis were clear-
cut and did not demonstrate trends for clinically relevant effects of SCL. We refrained from 
dichotomizing our data using a specific SCL value as cut-off point, as this statistical method is 
clearly inferior to the multivariate model applied.  
 In conclusion, our data suggest that SCL in patients with acute ischemic stroke are not 
associated with neurological deficit on admission, outcome or neurological recovery. 
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Table 1: Evaluation of independent predictors of neurological recovery at three months (ΔNIHSS) 
using multivariate binary logistic regression analysis in 837 patients with first-ever acute 
ischemic stroke.  
 
 
Variable Odds ratio 95% CI p 
Age (years) 1.0 0.98-1.02 0.99 
Sex (male/female) 1.1 0.68-1.65 0.79 
Diabetes mellitus (yes/no) 0.98 0.55-1.76 0.96 
Arterial hypertension (yes/no) 0.82 0.53-1.29 0.4 
Smoking (yes/no) 0.54 0.36-0.83 0.005 
Stroke etiology*  1.23 1.1-1.43 0.005 
SCL (mmol/l) 0.99 0.84-1.17 0.89 
NIHSS0  1.52 1.36-1.7 < 0.001 
 
*: (cardioembolic/ atherothrombotic/ lacunar/ other known etiology/ unknown etiology) 
 
  
   
Figure 1: Relationship between SCL and neurological outcome at 3 months following acute 
ischemic stroke. 
